We describe seven patients who developed symptoms including severe hea
dache, circumoral paresthesia, and facial flushing during high-dose ca
rmustine (BCNU) infusion as part of the preparative regimen for autolo
gous peripheral blood stem cell (PBSC) transplantation for metastatic
breast cancer, Five patients responded to pain medications, including
partial and complete opiate receptor agonists, Premedication of subseq
uent doses of BCNU with corticosteroids, pain medications, or benzodia
zepines lessened, but did not prevent the same symptoms from recurring
, The incidence and mechanism of this toxicity are unknown, but this a
dverse syndrome should be considered when administering high-dose BCNU
infusions.